S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q4 2025

RA Capital Management

Period: Q4 2025 Β· Filed: 2026-02-17
View on SEC EDGAR β†—
AUM
$9.76B
Total portfolio value
Positions
71
Reported securities
Top Holding
ASND
22.5% $2.19B
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2026-02-17) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S - ADR$2.19B22.46%$213.24$274.50+28.7%
22.5%
CDTXCIDARA THERAPEUTICS INC$743.4M7.62%β€”β€”
7.6%
RYTMRHYTHM PHARMACEUTICALS INC$713.6M7.31%$107.04$114.17+6.7%
7.3%
RNAMAVIDITY BIOSCIENCES INC$623.3M6.39%β€”β€”
6.4%
PCVXVAXCYTE INC$494.8M5.07%$46.14$58.39+26.6%
5.1%
SIONSIONNA THERAPEUTICS INC$407.5M4.17%$41.14$43.99+6.9%
4.2%
NAMSNEWAMSTERDAM PHARMA CO NV$335.0M3.43%$35.08$34.83-0.7%
3.4%
TYRATYRA BIOSCIENCES INC$320.7M3.29%$26.29$30.62+16.5%
3.3%
WVEWAVE LIFE SCIENCES LTD$309.4M3.17%$17.00$6.26-63.2%
3.2%
MLYSMINERALYS THERAPEUTICS INC$265.8M2.72%$36.29$27.69-23.7%
2.7%
EWTXEDGEWISE THERAPEUTICS INC$258.8M2.65%$24.82$39.56+59.4%
2.6%
SEPNSEPTERNA INC$195.0M2.00%$27.88$34.00+21.9%
2.0%
NUVLNUVALENT INC-A$189.1M1.94%$100.59$123.73+23.0%
1.9%
IRONDISC MEDICINE INC$156.9M1.61%$79.41$76.26-4.0%
1.6%
JANXJANUX THERAPEUTICS INC$154.4M1.58%$13.80$15.54+12.6%
1.6%
PEPGPEPGEN INC$130.6M1.34%$6.51$1.76-73.0%
1.3%
TSHATAYSHA GENE THERAPIES INC$129.6M1.33%$5.50$6.53+18.7%
1.3%
SPRYARS PHARMACEUTICALS INC$126.5M1.30%$11.65$8.56-26.5%
1.3%
BCRXBIOCRYST PHARMACEUTICALS INC$123.5M1.26%$7.80$9.84+26.1%
1.3%
BCAXBICARA THERAPEUTICS INC$117.1M1.20%$16.83$29.00+72.3%
1.2%
PRAXPRAXIS PRECISION MEDICINES I$110.2M1.13%$294.74$318.52+8.1%
1.1%
GHRSGH RESEARCH PLC$97.5M1.00%$12.70$27.01+112.7%
1.0%
GERNGERON CORP$84.2M0.86%$1.32$1.36+3.0%
0.9%
ACLXARCELLX INC$82.6M0.85%$65.20β€”
0.8%
CLYMCLIMB BIO INC$77.7M0.80%$4.00$12.90+222.5%
0.8%
VORVOR BIOPHARMA INC$70.7M0.72%$13.08$20.59+57.4%
0.7%
BLTEBELITE BIO INC - ADR$69.2M0.71%$159.96$146.63-8.3%
0.7%
FULCFULCRUM THERAPEUTICS INC$68.5M0.70%$11.31$3.84-66.0%
0.7%
LENZLENZ THERAPEUTICS INC$66.9M0.68%$16.00$5.89-63.2%
0.7%
DNTHDIANTHUS THERAPEUTICS INC$66.4M0.68%$41.21$94.34+128.9%
0.7%

Quarter-on-Quarter Activity

Q4 2025 vs. Q3 2025

New Positions (8)

TickerIssuerNotionalSince Filing
BCRXBIOCRYST PHARMACEUTICALS INC$123.5M+26.1%
PRAXPRAXIS PRECISION MEDICINES I$110.2M+8.1%
OLMAOLEMA PHARMACEUTICALS INC$65.0M
EVMNEVOMMUNE INC$59.2M
SYRESPYRE THERAPEUTICS INC$53.1M
LXEOLEXEO THERAPEUTICS INC$49.6M
CAPRCAPRICOR THERAPEUTICS INC$43.5M
GRALGRAIL INC$36.7M

Exited Positions (8)

TickerIssuerNotional
ETNB89BIO INC$292.4M
SRRKSCHOLAR ROCK HOLDING CORP$43.5M
GPCRSTRUCTURE THERAPEUTICS INC$42.5M
MTSRMETSERA INC$35.4M
TVTXTRAVERE THERAPEUTICS INC$27.5M
LRMRLARIMAR THERAPEUTICS INC$19.5M
TNGXTANGO THERAPEUTICS INC$16.8M
PRMEPRIME MEDICINE INC$16.6M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
JBIOJADE BIOSCIENCES INC$47.5M+245.6%
DSGNDESIGN THERAPEUTICS INC$10.1M+207.2%
VORVOR BIOPHARMA INC$-25.9M+172.7%+57.4%
NUVLNUVALENT INC-A$81.3M+50.8%+23.0%
MNPRMONOPAR THERAPEUTICS INC$1.8M+30.5%
IRONDISC MEDICINE INC$52.7M+25.3%-4.0%
LBRXLB PHARMACEUTICALS INC$21.1M+24.3%
FDMT4D MOLECULAR THERAPEUTICS IN$2.7M+23.9%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
CLYMCLIMB BIO INC$14.6M-64.1%+222.5%
ACLXARCELLX INC$-166.7M-58.3%
BLTEBELITE BIO INC - ADR$4.4M-50.6%-8.3%
DNTHDIANTHUS THERAPEUTICS INC$-46.4M-43.8%+128.9%
FULCFULCRUM THERAPEUTICS INC$-25.6M-40.8%-66.0%
PCVXVAXCYTE INC$63.8M-10.4%+26.6%
NAMSNEWAMSTERDAM PHARMA CO NV$46.7M-5.8%-0.7%
SIONSIONNA THERAPEUTICS INC$100.3M-5.2%+6.9%
← Back to Hedge Funds